(1) Within 20 days after the day on which the committee proceedings described in Section 62A-16-204 end, the committee shall submit: (a) a written report to the executive director that includes: (i) the advisory opinions made under Subsection 62A-16-204(6); and (ii) any recommendations regarding action that should be taken in relation to an employee of the department or a person who contracts with the department; (b) a copy of the report described in Subsection (1)(a) to: (i) the director, or the director's designee, of the office or division to which the fatality relates; and (ii) the regional director, or the regional director's designee, of the region to which the fatality relates; and (c) a copy of the report described in Subsection (1)(a), with only identifying information redacted, to the Office of Legislative Research and General Counsel.

(a) a written report to the executive director that includes: (i) the advisory opinions made under Subsection 62A-16-204(6); and (ii) any recommendations regarding action that should be taken in relation to an employee of the department or a person who contracts with the department;

(i) the advisory opinions made under Subsection 62A-16-204(6); and

(ii) any recommendations regarding action that should be taken in relation to an employee of the department or a person who contracts with the department;

(b) a copy of the report described in Subsection (1)(a) to: (i) the director, or the director's designee, of the office or division to which the fatality relates; and (ii) the regional director, or the regional director's designee, of the region to which the fatality relates; and

(i) the director, or the director's designee, of the office or division to which the fatality relates; and

(ii) the regional director, or the regional director's designee, of the region to which the fatality relates; and

(c) a copy of the report described in Subsection (1)(a), with only identifying information redacted, to the Office of Legislative Research and General Counsel.

(2) Within 20 days after the day on which the director described in Subsection (1)(b)(i) receives a copy of the report described in Subsection (1)(a), the director shall provide a written response to the director of the Office of Quality and Design and a copy of the response, with only identifying information redacted, to the Office of Legislative Research and General Counsel, if the report: (a) indicates that a law, rule, policy, or procedure was not complied with; (b) indicates that the fatality was not responded to properly; (c) recommends that a law, rule, policy, or procedure be changed; or (d) indicates that additional training is needed.

(a) indicates that a law, rule, policy, or procedure was not complied with;

(b) indicates that the fatality was not responded to properly;

(c) recommends that a law, rule, policy, or procedure be changed; or

(d) indicates that additional training is needed.

(3) The response described in Subsection (2) shall include a plan of action to implement any recommended improvements within the office or division.

(4) Within 30 days after the day on which the executive director receives the response described in Subsection (2), the executive director, or the executive director's designee shall: (a) review the plan of action described in Subsection (3); (b) make any written response that the executive director or the executive director's designee determines is necessary; (c) provide a copy of the written response described in Subsection (4)(b), with only identifying information redacted, to the Office of Legislative Research and General Counsel; and (d) provide an unredacted copy of the response described in Subsection (4)(b) to the director of the Office of Quality and Design.

(a) review the plan of action described in Subsection (3);

(b) make any written response that the executive director or the executive director's designee determines is necessary;

(c) provide a copy of the written response described in Subsection (4)(b), with only identifying information redacted, to the Office of Legislative Research and General Counsel; and

(d) provide an unredacted copy of the response described in Subsection (4)(b) to the director of the Office of Quality and Design.

(5) A report described in Subsection (1) and each response described in this section is a protected record.

(6) (a) As used in this Subsection (6), "fatality review document" means any document created in connection with, or as a result of, a fatality review or a decision whether to conduct a fatality review, including: (i) a report described in Subsection (1); (ii) a response described in this section; (iii) a recommendation regarding whether a fatality review should be conducted; (iv) a decision to conduct a fatality review; (v) notes of a person who participates in a fatality review; (vi) notes of a person who reviews a fatality review report; (vii) minutes of a fatality review; (viii) minutes of a meeting where a fatality review report is reviewed; and (ix) minutes of, documents received in relation to, and documents generated in relation to, the portion of a meeting of the Health and Human Services Interim Committee or the Child Welfare Legislative Oversight Panel that a fatality review report or a document described in this Subsection (6)(a) is reviewed or discussed. (b) A fatality review document is not subject to discovery, subpoena, or similar compulsory process in any civil, judicial, or administrative proceeding, nor shall any individual or organization with lawful access to the data be compelled to testify with regard to a report described in Subsection (1) or a response described in this section. (c) The following are not admissible as evidence in a civil, judicial, or administrative proceeding: (i) a fatality review document; and (ii) an executive summary described in Subsection 62A-16-302(4).

(a) As used in this Subsection (6), "fatality review document" means any document created in connection with, or as a result of, a fatality review or a decision whether to conduct a fatality review, including: (i) a report described in Subsection (1); (ii) a response described in this section; (iii) a recommendation regarding whether a fatality review should be conducted; (iv) a decision to conduct a fatality review; (v) notes of a person who participates in a fatality review; (vi) notes of a person who reviews a fatality review report; (vii) minutes of a fatality review; (viii) minutes of a meeting where a fatality review report is reviewed; and (ix) minutes of, documents received in relation to, and documents generated in relation to, the portion of a meeting of the Health and Human Services Interim Committee or the Child Welfare Legislative Oversight Panel that a fatality review report or a document described in this Subsection (6)(a) is reviewed or discussed.

(i) a report described in Subsection (1);

(ii) a response described in this section;

(iii) a recommendation regarding whether a fatality review should be conducted;

(iv) a decision to conduct a fatality review;

(v) notes of a person who participates in a fatality review;

(vi) notes of a person who reviews a fatality review report;

(vii) minutes of a fatality review;

(viii) minutes of a meeting where a fatality review report is reviewed; and

(ix) minutes of, documents received in relation to, and documents generated in relation to, the portion of a meeting of the Health and Human Services Interim Committee or the Child Welfare Legislative Oversight Panel that a fatality review report or a document described in this Subsection (6)(a) is reviewed or discussed.

(b) A fatality review document is not subject to discovery, subpoena, or similar compulsory process in any civil, judicial, or administrative proceeding, nor shall any individual or organization with lawful access to the data be compelled to testify with regard to a report described in Subsection (1) or a response described in this section.

(c) The following are not admissible as evidence in a civil, judicial, or administrative proceeding: (i) a fatality review document; and (ii) an executive summary described in Subsection 62A-16-302(4).

(i) a fatality review document; and

(ii) an executive summary described in Subsection 62A-16-302(4).